UK Stocks Priced Below Estimated Intrinsic Value

As the United Kingdom's FTSE 100 index faces pressure from weak trade data out of China and a global economic slowdown, investors are keeping a close eye on market movements. In such an environment, identifying stocks priced below their estimated intrinsic value can offer potential opportunities for those looking to navigate the current challenges effectively.

Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom

Name	Current Price	Fair Value (Est)	Discount (Est)
Yü Group (AIM:YU.)	£18.20	£34.42	47.1%
Polar Capital Holdings (AIM:POLR)	£7.71	£14.41	46.5%
Playtech (LSE:PTEC)	£3.786	£7.32	48.2%
On the Beach Group (LSE:OTB)	£1.876	£3.66	48.8%
Kistos Holdings (AIM:KIST)	£2.72	£5.31	48.8%
FDM Group (Holdings) (LSE:FDM)	£1.232	£2.33	47.1%
Eurocell (LSE:ECEL)	£1.18	£2.23	47.1%
Entain (LSE:ENT)	£5.414	£10.49	48.4%
Diaceutics (AIM:DXRX)	£1.435	£2.85	49.7%
Bridgepoint Group (LSE:BPT)	£3.206	£5.98	46.4%

Click here to see the full list of 43 stocks from our Undervalued UK Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Dr. Martens (LSE:DOCS)

Overview: Dr. Martens plc is involved in the design, development, procurement, marketing, sale, and distribution of footwear with a market cap of £740.81 million.

Operations: The company's revenue segment is primarily derived from footwear, amounting to £764.90 million.

Estimated Discount To Fair Value: 16%

Dr. Martens appears undervalued based on cash flow analysis, trading at £0.77, below the estimated future cash flow value of £0.92. Despite a decrease in sales to £764.9 million, net income rose substantially to £23.8 million, indicating improved profitability with earnings growing 413% over the past year. Earnings are expected to grow significantly faster than the UK market at 30% annually over three years, though revenue growth remains modest at 4.5%.

• Our comprehensive growth report raises the possibility that Dr. Martens is poised for substantial financial growth.
• Dive into the specifics of Dr. Martens here with our thorough financial health report.

Norcros (LSE:NXR)

Overview: Norcros plc, with a market cap of £281.96 million, designs and supplies bathroom and kitchen products across the United Kingdom, South Africa, Europe, and other international markets.

Operations: The company generates revenue from its Building Products segment, amounting to £393.40 million.

Estimated Discount To Fair Value: 37.3%

Norcros is trading at £3.16, significantly below its estimated future cash flow value of £5.04, suggesting it may be undervalued based on cash flows. Despite a modest revenue forecast of 5.6% annually, earnings are expected to grow significantly at 27.7% per year, outpacing the UK market's growth rate. Recent strategic moves include exploring the sale of its South African business and pursuing acquisitions to enhance focus on its core bathroom segment while maintaining financial flexibility.

• Our expertly prepared growth report on Norcros implies its future financial outlook may be stronger than recent results.
• Click here and access our complete balance sheet health report to understand the dynamics of Norcros.

Wise Group (LSE:WISE)

Overview: Wise Group plc offers cross-border and domestic financial services across the UK, Europe, Asia-Pacific, North America, and globally with a market cap of £9.08 billion.

Operations: The company generates revenue of $2.50 billion from its cross-border and domestic financial services operations.

Estimated Discount To Fair Value: 16%

Wise Group is trading at £8.86, below its estimated future cash flow value of £10.54, indicating potential undervaluation based on cash flows. Revenue growth is forecasted at 13.5% per year, outpacing the UK market's 4.3%. Despite legal challenges over alleged misleading statements about regulatory risks, Wise continues to expand globally with new integrations like Malaysia's DuitNow payments infrastructure, enhancing transaction efficiency and reducing costs for users worldwide.

• In light of our recent growth report, it seems possible that Wise Group's financial performance will exceed current levels.
• Navigate through the intricacies of Wise Group with our comprehensive financial health report here.

Key Takeaways

• Discover the full array of 43 Undervalued UK Stocks Based On Cash Flows right here.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com